Cargando…
Achieving the Cure of Follicular Lymphoma: is it Time to Finalize Treatment Strategies to Reach This Goal in a Subset of Patients?
Autores principales: | Pulsoni, A., Assanto, G.M., Salvatori, M., Musiu, P., Luise, C., Passucci, M., Lapietra, G., Pappalardo, L., Annechini, G., D’Elia, G.M., Martelli, M., Del Giudice, I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000943/ https://www.ncbi.nlm.nih.gov/pubmed/36908868 http://dx.doi.org/10.4084/MJHID.2023.018 |
Ejemplares similares
-
High Basal Maximal Standardized Uptake Value (SUV(max)) in Follicular Lymphoma Identifies Patients with a Low Risk of Long-Term Relapse
por: Assanto, Giovanni Manfredi, et al.
Publicado: (2021) -
S219: PREDICTING THROMBOTIC RISK IN PATIENTS WITH HODGKIN LYMPHOMA: A MULTICENTRIC STUDY OF THROLY AND KHORANA RISK SCORES
por: Assanto, Giovanni Manfredi, et al.
Publicado: (2023) -
The current role of interferon in hairy cell leukaemia: clinical and molecular aspects
por: Assanto, Giovanni M., et al.
Publicado: (2021) -
Infectious Aetiology of Marginal Zone Lymphoma and Role of Anti-Infective Therapy
por: Perrone, Salvatore, et al.
Publicado: (2016) -
RR6 prognostic model provides information about survival for myelofibrosis treated with ruxolitinib: validation in a real-life cohort
por: Scalzulli, Emilia, et al.
Publicado: (2022)